BNTC · Categories · Form 4

BNTC - SEC Form 4 insider transactions

Benitec Biopharma Inc. (BNTC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BNTC

• 11d
  SEC Form 4 filed by Director Friedman David Matthew

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 133d
  SEC Form 4 filed by Director Mates Sharon

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 187d
  SEC Form 4 filed by Benitec Biopharma Inc.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 187d
  SEC Form 4 filed by Director Mehta Kishan

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 187d
  SEC Form 4 filed by Director Smith Edward F

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 187d
  SEC Form 4 filed by Benitec Biopharma Inc.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 187d
  SEC Form 4 filed by Benitec Biopharma Inc.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 200d
  SEC Form 4 filed by Chief Operating Officer Mukadam Sophie

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 200d
  SEC Form 4 filed by Chief Executive Officer Banks Jerel A.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 200d
  SEC Form 4 filed by Chief Financial Officer Boston Megan

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 213d
  SEC Form 4 filed by Director Mates Sharon

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 452d
  Director Buchi J Kevin gifted 103,626 shares and received a gift of 103,626 shares, decreasing direct ownership by 100% to 284 units (SEC Form 4)

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 462d
  Director Buchi J Kevin exercised 51,813 shares at a strike of $3.86, increasing direct ownership by 99% to 103,910 units (SEC Form 4)

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 544d
  SEC Form 4 filed by Director Mehta Kishan

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 544d
  SEC Form 4 filed by Director Francis Peter

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 544d
  SEC Form 4 filed by Director Buchi J Kevin

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 544d
  SEC Form 4 filed by Director Smith Edward F

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 544d
  SEC Form 4 filed by Chief Executive Officer Banks Jerel A.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 544d
  SEC Form 4 filed by Executive Director Boston Megan

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 616d
  Director Suvretta Capital Management, Llc exercised 7,137,763 in-the-money shares at a strike of $2.96 (SEC Form 4)

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 822d
  SEC Form 4 filed by Banks Jerel A.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 822d
  SEC Form 4 filed by Boston Megan

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 914d
  SEC Form 4 filed by Smith Edward F

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 914d
  SEC Form 4 filed by Francis Peter

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 914d
  SEC Form 4 filed by Buchi J Kevin

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1029d
  SEC Form 4: Boston Megan bought 25,907 shares

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1029d
  SEC Form 4: Buchi J Kevin bought 51,813 shares, increasing direct ownership by 18,244% to 52,097 units

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1089d
  SEC Form 4 filed by Boston Megan

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1089d
  SEC Form 4 filed by Banks Jerel A.

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1277d
  SEC Form 4 filed by Smith Edward F

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1277d
  SEC Form 4 filed by Buchi J Kevin

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1277d
  SEC Form 4 filed by Francis Peter

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1641d
  SEC Form 4 filed by Buchi J Kevin

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1641d
  SEC Form 4 filed by Smith Edward F

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1641d
  SEC Form 4 filed by Francis Peter

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)
• 1642d
  SEC Form 4: Oliveira Steven Michael bought $1,497,454 worth of shares (331,877 units at $4.51)

  4 - Benitec Biopharma Inc. (0001808898) (Issuer)

Other BNTC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends